|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1991-1-14
|
|
pubmed:abstractText |
The objective of this study was to examine the effect of low-dose aspirin (325 mg on alternate days) on the primary prevention of angina pectoris in the United States Physicians' Health Study. Despite a postulated role of platelets in atherogenesis and myocardial ischemia, the effect of chronic platelet inhibition on the development of clinical angina pectoris is unknown.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0002-9343
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
772-6
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:2252045-Adult,
pubmed-meshheading:2252045-Aged,
pubmed-meshheading:2252045-Aged, 80 and over,
pubmed-meshheading:2252045-Angina Pectoris,
pubmed-meshheading:2252045-Aspirin,
pubmed-meshheading:2252045-Double-Blind Method,
pubmed-meshheading:2252045-Follow-Up Studies,
pubmed-meshheading:2252045-Humans,
pubmed-meshheading:2252045-Incidence,
pubmed-meshheading:2252045-Male,
pubmed-meshheading:2252045-Middle Aged,
pubmed-meshheading:2252045-Physicians,
pubmed-meshheading:2252045-Placebos,
pubmed-meshheading:2252045-Primary Prevention,
pubmed-meshheading:2252045-Proportional Hazards Models,
pubmed-meshheading:2252045-Risk Factors,
pubmed-meshheading:2252045-Time Factors,
pubmed-meshheading:2252045-United States
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians.
|
|
pubmed:affiliation |
Channing Laboratory, Department of Medicine, Harvard Medical School.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
